JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2007; 49:472-479, doi:10.1016/j.jacc.2006.09.038 (Published online 12 January 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
j.jacc.2006.09.038v1
49/4/472    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sachdev, V.
Right arrow Articles by Gladwin, M. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sachdev, V.
Right arrow Articles by Gladwin, M. T.

CLINICAL RESEARCH: DIASTOLIC DYSFUNCTION

Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease

Vandana Sachdev, MD*,*, Roberto F. Machado, MD{dagger}, Yukitaka Shizukuda, MD, PhD*, Yesoda N. Rao, MD*, Stanislav Sidenko*, Inez Ernst, RN, RDCS*, Marilyn St. Peter, RDCS*, Wynona A. Coles, RRT{dagger}, Douglas R. Rosing, MD*, William C. Blackwelder, PhD{ddagger}, Oswaldo Castro, MD§, Gregory J. Kato, MD{dagger} and Mark T. Gladwin, MD{dagger},{ddagger},1

* Cardiovascular Branch, Echocardiography Laboratory, National Heart, Lung, and Blood Institute, Bethesda, Maryland
{dagger} Vascular Medicine Branch, Echocardiography Laboratory, National Heart, Lung, and Blood Institute, Bethesda, Maryland
{ddagger} Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, Maryland
§ Center for Sickle Cell Disease, Howard University College of Medicine, Washington, DC.

Manuscript received May 8, 2006; revised manuscript received September 12, 2006, accepted September 28, 2006.

* Reprint requests and correspondence: Dr. Vandana Sachdev, Echocardiography Laboratory, Cardiovascular Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, 10 Center Drive, CRC, 5-1436, Bethesda, Maryland 20892-1454. (Email: sachdevv{at}nhlbi.nih.gov).

OBJECTIVES: The goal of this study was to characterize left ventricular diastolic function in the sickle cell disease (SCD) population and to relate echocardiographic measures of dysfunction with pulmonary hypertension and mortality.

BACKGROUND: Pulmonary hypertension has been identified as a predictor of death in the adult SCD population. Although diastolic dysfunction is also observed in this population, its prevalence, association with high pulmonary artery systolic pressure, and attributable mortality remain unknown.

METHODS: Diastolic function assessment using tissue Doppler imaging was performed in a group of 141 SCD patients. Conventional echocardiographic parameters of diastolic function were performed in a total of 235 SCD patients.

RESULTS: Diastolic dysfunction was present in 18% of patients. A combination of diastolic dysfunction and pulmonary hypertension was present in 11% of patients, and diastolic dysfunction accounted for only 10% to 20% of the variability in tricuspid regurgitation (TR) jet velocity. Diastolic dysfunction, as reflected by a low E/A ratio, was associated with mortality with a risk ratio of 3.5 (95% confidence interval 1.5 to 8.4, p < 0.001), even after adjustment for tricuspid regurgitation (TR) jet velocity. The presence of both diastolic dysfunction and pulmonary hypertension conferred a risk ratio for death of 12.0 (95% confidence interval 3.8 to 38.1, p < 0.001).

CONCLUSIONS: Diastolic dysfunction and pulmonary hypertension each contribute independently to prospective mortality in patients with SCD. Patients with both risk factors have an extremely poor prognosis. These data support the implementation of echocardiographic screening of adult patients with SCD to identify high-risk individuals for further evaluation.

Abbreviations and Acronyms
  BP = blood pressure
  LV = left ventricle/ventricular
  LVH = left ventricular hypertrophy
  PH = pulmonary hypertension
  RV = right ventricle/ventricular
  RWT = relative wall thickness
  SCD = sickle cell disease
  TR = tricuspid regurgitant/regurgitation




This article has been cited by other articles:


Home page
haematolHome page
P. P. Landburg, T. Teerlink, E. J. van Beers, F. A.J. Muskiet, M. C. Kappers-Klunne, J. W.J. van Esser, M. R. Mac Gillavry, B. J. Biemond, D. P.M. Brandjes, A. J. Duits, et al.
Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension
Haematologica, September 1, 2008; 93(9): 1410 - 1412.
[Full Text] [PDF]


Home page
JAMAHome page
C. F. Barnett, P. Y. Hsue, and R. F. Machado
Pulmonary Hypertension: An Increasingly Recognized Complication of Hereditary Hemolytic Anemias and HIV Infection
JAMA, January 23, 2008; 299(3): 324 - 331.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. R. Morris, J. H. Suh, W. Hagar, S. Larkin, D. A. Bland, M. H. Steinberg, E. P. Vichinsky, M. Shigenaga, B. Ames, F. A. Kuypers, et al.
Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease
Blood, January 1, 2008; 111(1): 402 - 410.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. O. Ntim, B. Upadhya, and J. Cruz
Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell Disease
J. Am. Coll. Cardiol., July 24, 2007; 50(4): 378 - 378.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Sachdev, R. F. Machado, W. C. Blackwelder, G. J. Kato, and M. T. Gladwin
Reply
J. Am. Coll. Cardiol., July 24, 2007; 50(4): 378 - 379.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Anthi, R. F. Machado, M. L. Jison, A. M. Taveira-DaSilva, L. J. Rubin, L. Hunter, C. J. Hunter, W. Coles, J. Nichols, N. A. Avila, et al.
Hemodynamic and Functional Assessment of Patients with Sickle Cell Disease and Pulmonary Hypertension
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1272 - 1279.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
E. Voskaridou, G. Tsetsos, A. Tsoutsias, E. Spyropoulou, D. Christoulas, and E. Terpos
Pulmonary hypertension in patients with sickle cell/{beta} thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations
Haematologica, June 1, 2007; 92(6): 738 - 743.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
M. J. Telen
Role of Adhesion Molecules and Vascular Endothelium in the Pathogenesis of Sickle Cell Disease
Hematology, January 1, 2007; 2007(1): 84 - 90.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2007 by the American College of Cardiology Foundation.